MBT
REGN icon

Montecito Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Montecito Bank & Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-317
Closed -$245K – 279
2026
Q1 		$245K Hold
317
– – 0.04% 250
2025
Q4 		$245K Sell
317
-70
-18% -$47.5K 0.04% 250
2025
Q3 		$218K Buy
+387
New +$219K 0.03% 269
2025
Q1 		$808K Buy
1,274
+22
+2% +$15.1K 0.14% 153
2024
Q4 		$892K Buy
1,252
+138
+12% +$116K 0.15% 144
2024
Q3 		$1.17M Buy
1,114
+526
+89% +$585K 0.2% 116
2024
Q2 		$618K Buy
588
+48
+9% +$46.5K 0.13% 155
2024
Q1 		$520K Buy
+540
New +$513K 0.1% 174

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Montecito Bank & Trust's REGN Position: Q2 2026 in Review

Montecito Bank & Trust sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 317 shares — an estimated $245K sold.

Montecito Bank & Trust first reported a position in REGN in Q1 2024 and held it in 8 quarters. The position peaked at $1.17M in Q3 2024. 237 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Montecito Bank & Trust reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Montecito Bank & Trust sold 317 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $245K.
  • Montecito Bank & Trust first reported a position in Regeneron Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • Montecito Bank & Trust's Regeneron Pharmaceuticals position peaked at $1.17M in Q3 2024.
  • 237 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Montecito Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.